| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 9.77e-06 | 4 | 26 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 2.44e-05 | 6 | 26 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 1.02e-04 | 884 | 26 | 7 | GO:0004930 | |
| GeneOntologyMolecularFunction | calmodulin binding | 2.10e-04 | 230 | 26 | 4 | GO:0005516 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 2.46e-04 | 18 | 26 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | protein-hormone receptor activity | 3.71e-04 | 22 | 26 | 2 | GO:0016500 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 6.71e-04 | 133 | 26 | 3 | GO:0008528 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 7.41e-04 | 31 | 26 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 7.79e-04 | 140 | 26 | 3 | GO:0001653 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 8.40e-04 | 33 | 26 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | 1.35e-03 | 1353 | 26 | 7 | GO:0004888 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 6.51e-03 | 296 | 26 | 3 | GO:0015291 | |
| GeneOntologyMolecularFunction | hormone binding | 7.90e-03 | 103 | 26 | 2 | GO:0042562 | |
| GeneOntologyBiologicalProcess | activation of adenylate cyclase activity | 1.04e-05 | 34 | 26 | 3 | GO:0007190 | |
| GeneOntologyBiologicalProcess | positive regulation of adenylate cyclase activity | 1.70e-05 | 40 | 26 | 3 | GO:0045762 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclase activity | 2.96e-05 | 48 | 26 | 3 | GO:0031281 | |
| GeneOntologyBiologicalProcess | positive regulation of lyase activity | 3.15e-05 | 49 | 26 | 3 | GO:0051349 | |
| GeneOntologyBiologicalProcess | regulation of adenylate cyclase activity | 5.52e-05 | 59 | 26 | 3 | GO:0045761 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 7.56e-05 | 359 | 26 | 5 | GO:0006874 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 8.35e-05 | 11 | 26 | 2 | GO:0071313 | |
| GeneOntologyBiologicalProcess | regulation of cyclase activity | 8.82e-05 | 69 | 26 | 3 | GO:0031279 | |
| GeneOntologyBiologicalProcess | regulation of lyase activity | 1.04e-04 | 73 | 26 | 3 | GO:0051339 | |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | 1.10e-04 | 389 | 26 | 5 | GO:0055074 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 1.38e-04 | 14 | 26 | 2 | GO:0071415 | |
| GeneOntologyBiologicalProcess | regulation of cytosolic calcium ion concentration | 1.58e-04 | 84 | 26 | 3 | GO:0051480 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | 2.23e-04 | 1395 | 26 | 8 | GO:0007186 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | 2.84e-04 | 752 | 26 | 6 | GO:1901699 | |
| GeneOntologyBiologicalProcess | response to caffeine | 3.16e-04 | 21 | 26 | 2 | GO:0031000 | |
| GeneOntologyBiologicalProcess | cellular response to ATP | 3.16e-04 | 21 | 26 | 2 | GO:0071318 | |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | 3.23e-04 | 266 | 26 | 4 | GO:0019722 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 4.25e-04 | 286 | 26 | 4 | GO:0007188 | |
| GeneOntologyBiologicalProcess | negative regulation of cytosolic calcium ion concentration | 4.50e-04 | 25 | 26 | 2 | GO:0051481 | |
| GeneOntologyBiologicalProcess | response to magnesium ion | 4.50e-04 | 25 | 26 | 2 | GO:0032026 | |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | 6.02e-04 | 866 | 26 | 6 | GO:0055082 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 6.11e-04 | 133 | 26 | 3 | GO:0007200 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 8.02e-04 | 146 | 26 | 3 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 8.18e-04 | 147 | 26 | 3 | GO:0051283 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 8.50e-04 | 149 | 26 | 3 | GO:0051282 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | 8.81e-04 | 611 | 26 | 5 | GO:0030003 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 9.18e-04 | 153 | 26 | 3 | GO:0051208 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | 9.54e-04 | 622 | 26 | 5 | GO:0006873 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | 9.54e-04 | 622 | 26 | 5 | GO:0098771 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 9.90e-04 | 37 | 26 | 2 | GO:0014808 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 1.10e-03 | 39 | 26 | 2 | GO:1903514 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | 1.16e-03 | 981 | 26 | 6 | GO:0019725 | |
| GeneOntologyBiologicalProcess | response to ATP | 1.16e-03 | 40 | 26 | 2 | GO:0033198 | |
| GeneOntologyBiologicalProcess | cellular response to alkaloid | 1.16e-03 | 40 | 26 | 2 | GO:0071312 | |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 1.16e-03 | 166 | 26 | 3 | GO:0014074 | |
| GeneOntologyBiologicalProcess | calcium ion transport into cytosol | 1.28e-03 | 42 | 26 | 2 | GO:0060402 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 1.40e-03 | 44 | 26 | 2 | GO:0070296 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | 1.63e-03 | 410 | 26 | 4 | GO:0046942 | |
| GeneOntologyBiologicalProcess | organic acid transport | 1.66e-03 | 412 | 26 | 4 | GO:0015849 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | 1.67e-03 | 705 | 26 | 5 | GO:0055080 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 1.74e-03 | 191 | 26 | 3 | GO:0007189 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | 1.79e-03 | 717 | 26 | 5 | GO:0050801 | |
| GeneOntologyBiologicalProcess | icosanoid secretion | 2.26e-03 | 56 | 26 | 2 | GO:0032309 | |
| GeneOntologyBiologicalProcess | amino acid import across plasma membrane | 2.42e-03 | 58 | 26 | 2 | GO:0089718 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 2.50e-03 | 217 | 26 | 3 | GO:0097553 | |
| GeneOntologyBiologicalProcess | protein localization to lysosome | 2.59e-03 | 60 | 26 | 2 | GO:0061462 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 2.67e-03 | 61 | 26 | 2 | GO:0007187 | |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 2.73e-03 | 224 | 26 | 3 | GO:0007204 | |
| Domain | RR_TM4-6 | 5.59e-06 | 3 | 26 | 2 | PF06459 | |
| Domain | Ryanrecept_TM4-6 | 5.59e-06 | 3 | 26 | 2 | IPR009460 | |
| Domain | RyR | 5.59e-06 | 3 | 26 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 5.59e-06 | 3 | 26 | 2 | IPR003032 | |
| Domain | Ryan_recept | 5.59e-06 | 3 | 26 | 2 | IPR013333 | |
| Domain | RIH_assoc | 2.79e-05 | 6 | 26 | 2 | PF08454 | |
| Domain | Gphrmn_rcpt_fam | 2.79e-05 | 6 | 26 | 2 | IPR002131 | |
| Domain | RIH_assoc-dom | 2.79e-05 | 6 | 26 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 2.79e-05 | 6 | 26 | 2 | PF08709 | |
| Domain | RYDR_ITPR | 2.79e-05 | 6 | 26 | 2 | PF01365 | |
| Domain | RIH_dom | 2.79e-05 | 6 | 26 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 2.79e-05 | 6 | 26 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 2.79e-05 | 6 | 26 | 2 | IPR015925 | |
| Domain | - | 2.79e-05 | 6 | 26 | 2 | 1.25.10.30 | |
| Domain | MIR | 8.33e-05 | 10 | 26 | 2 | PS50919 | |
| Domain | MIR | 8.33e-05 | 10 | 26 | 2 | PF02815 | |
| Domain | MIR | 8.33e-05 | 10 | 26 | 2 | SM00472 | |
| Domain | LRR_5 | 8.33e-05 | 10 | 26 | 2 | PF13306 | |
| Domain | LRR_5 | 8.33e-05 | 10 | 26 | 2 | IPR026906 | |
| Domain | MIR_motif | 8.33e-05 | 10 | 26 | 2 | IPR016093 | |
| Domain | GPCR_3_9-Cys_dom | 1.44e-04 | 13 | 26 | 2 | IPR011500 | |
| Domain | NCD3G | 1.44e-04 | 13 | 26 | 2 | PF07562 | |
| Domain | GPCR_3_CS | 1.68e-04 | 14 | 26 | 2 | IPR017979 | |
| Domain | GPCR_3 | 3.85e-04 | 21 | 26 | 2 | IPR000337 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 4.23e-04 | 22 | 26 | 2 | PS50259 | |
| Domain | 7tm_3 | 4.23e-04 | 22 | 26 | 2 | PF00003 | |
| Domain | GPCR_3_C | 4.23e-04 | 22 | 26 | 2 | IPR017978 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 4.23e-04 | 22 | 26 | 2 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 4.23e-04 | 22 | 26 | 2 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 4.23e-04 | 22 | 26 | 2 | PS00979 | |
| Domain | BTB | 7.79e-04 | 131 | 26 | 3 | PF00651 | |
| Domain | ANF_receptor | 1.20e-03 | 37 | 26 | 2 | PF01094 | |
| Domain | ANF_lig-bd_rcpt | 1.20e-03 | 37 | 26 | 2 | IPR001828 | |
| Domain | Peripla_BP_I | 1.34e-03 | 39 | 26 | 2 | IPR028082 | |
| Domain | BTB | 1.39e-03 | 160 | 26 | 3 | PS50097 | |
| Domain | BTB | 1.94e-03 | 180 | 26 | 3 | SM00225 | |
| Domain | GPCR_Rhodpsn_7TM | 2.06e-03 | 670 | 26 | 5 | IPR017452 | |
| Domain | BTB/POZ_dom | 2.10e-03 | 185 | 26 | 3 | IPR000210 | |
| Domain | 7tm_1 | 2.15e-03 | 677 | 26 | 5 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 2.27e-03 | 685 | 26 | 5 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 2.35e-03 | 691 | 26 | 5 | PS50262 | |
| Domain | GPCR_Rhodpsn | 2.37e-03 | 692 | 26 | 5 | IPR000276 | |
| Domain | SPRY | 6.48e-03 | 87 | 26 | 2 | SM00449 | |
| Domain | SPRY | 7.53e-03 | 94 | 26 | 2 | PF00622 | |
| Domain | SPRY_dom | 7.53e-03 | 94 | 26 | 2 | IPR003877 | |
| Domain | B30.2/SPRY | 7.68e-03 | 95 | 26 | 2 | IPR001870 | |
| Domain | B302_SPRY | 7.68e-03 | 95 | 26 | 2 | PS50188 | |
| Domain | LRRNT | 8.16e-03 | 98 | 26 | 2 | IPR000372 | |
| Domain | LRRNT | 8.16e-03 | 98 | 26 | 2 | SM00013 | |
| Domain | - | 9.76e-03 | 321 | 26 | 3 | 3.80.10.10 | |
| Domain | MFS | 9.84e-03 | 108 | 26 | 2 | PS50850 | |
| Domain | L_dom-like | 1.03e-02 | 328 | 26 | 3 | IPR032675 | |
| Domain | Ion_trans_dom | 1.09e-02 | 114 | 26 | 2 | IPR005821 | |
| Domain | Ion_trans | 1.09e-02 | 114 | 26 | 2 | PF00520 | |
| Domain | MFS_dom | 1.48e-02 | 134 | 26 | 2 | IPR020846 | |
| Domain | EF-hand_1 | 1.88e-02 | 152 | 26 | 2 | PF00036 | |
| Pathway | WP_GPCRS_NONODORANT | 2.47e-06 | 266 | 22 | 6 | MM15843 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 6.71e-06 | 178 | 22 | 5 | M2890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RORA_MEDIATED_TRANSCRIPTION | 2.32e-05 | 5 | 22 | 2 | M49011 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ATXN1_TO_RORA_MEDIATED_TRANSCRIPTION | 3.47e-05 | 6 | 22 | 2 | M47665 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 3.83e-05 | 430 | 22 | 6 | MM15160 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 3.83e-05 | 646 | 22 | 7 | MM14962 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 5.19e-05 | 272 | 22 | 5 | M13380 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 5.79e-05 | 463 | 22 | 6 | M507 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 6.51e-05 | 702 | 22 | 7 | M746 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.27e-04 | 11 | 22 | 2 | M47958 | |
| Pathway | REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS | 1.52e-04 | 12 | 22 | 2 | M13070 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 1.79e-04 | 13 | 22 | 2 | M39589 | |
| Pathway | REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS | 2.41e-04 | 15 | 22 | 2 | MM14972 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.91e-04 | 19 | 22 | 2 | M47760 | |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 5.27e-04 | 22 | 22 | 2 | M39795 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 1.19e-03 | 33 | 22 | 2 | M39875 | |
| Pathway | PID_ARF6_PATHWAY | 1.34e-03 | 35 | 22 | 2 | M86 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 1.37e-03 | 143 | 22 | 3 | MM15055 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 1.50e-03 | 37 | 22 | 2 | MM15067 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 1.55e-03 | 330 | 22 | 4 | M18334 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 1.60e-03 | 333 | 22 | 4 | MM14963 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 1.66e-03 | 39 | 22 | 2 | M793 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 1.69e-03 | 154 | 22 | 3 | MM15974 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 1.75e-03 | 156 | 22 | 3 | M39475 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 1.79e-03 | 157 | 22 | 3 | M4904 | |
| Pathway | WP_15Q25_COPY_NUMBER_VARIATION | 2.31e-03 | 46 | 22 | 2 | M48105 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 2.72e-03 | 50 | 22 | 2 | M47951 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 2.89e-03 | 186 | 22 | 3 | MM15994 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 3.17e-03 | 54 | 22 | 2 | MM15202 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 3.17e-03 | 54 | 22 | 2 | M27460 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 4.07e-03 | 210 | 22 | 3 | MM15043 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 4.46e-03 | 217 | 22 | 3 | M18437 | |
| Pathway | WP_GPCRS_PEPTIDE | 5.27e-03 | 70 | 22 | 2 | MM15959 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 1651314 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 18162522 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 2293030 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 14550562 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 11312274 | ||
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 5.37e-07 | 2 | 26 | 2 | 21531043 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 16678258 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 14985349 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 22309849 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 8898078 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 9242641 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 18403125 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 1.61e-06 | 3 | 26 | 2 | 10788707 | |
| Pubmed | RYR2 proteins contribute to the formation of Ca(2+) sparks in smooth muscle. | 1.61e-06 | 3 | 26 | 2 | 15024040 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 18434746 | ||
| Pubmed | Control of Neuronal Ryanodine Receptor-Mediated Calcium Signaling by Calsenilin. | 1.61e-06 | 3 | 26 | 2 | 29730765 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 8747461 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 25239916 | ||
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 1.61e-06 | 3 | 26 | 2 | 7621815 | |
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 1.61e-06 | 3 | 26 | 2 | 9204703 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 18643873 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 11159936 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 7876312 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 21881589 | ||
| Pubmed | Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors. | 1.61e-06 | 3 | 26 | 2 | 11847099 | |
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 1.61e-06 | 3 | 26 | 2 | 10473538 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 7959768 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 1.61e-06 | 3 | 26 | 2 | 12213830 | |
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 1.61e-06 | 3 | 26 | 2 | 4600883 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 7635066 | ||
| Pubmed | Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity. | 1.61e-06 | 3 | 26 | 2 | 15889138 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 9384575 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 18206662 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 9607712 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 23482488 | ||
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 3.22e-06 | 4 | 26 | 2 | 23413940 | |
| Pubmed | 3.82e-06 | 143 | 26 | 4 | 20424473 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 33060591 | ||
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 5.37e-06 | 5 | 26 | 2 | 19011160 | |
| Pubmed | KAISO, a critical regulator of p53-mediated transcription of CDKN1A and apoptotic genes. | 5.37e-06 | 5 | 26 | 2 | 25288747 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 23918386 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 19549818 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 19009018 | ||
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 8.05e-06 | 6 | 26 | 2 | 26025922 | |
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 23463619 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 8.05e-06 | 6 | 26 | 2 | 16844763 | |
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 8.05e-06 | 6 | 26 | 2 | 14592808 | |
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 8.05e-06 | 6 | 26 | 2 | 25966694 | |
| Pubmed | Expression of astrocyte-related receptors in cortical dysplasia with intractable epilepsy. | 1.13e-05 | 7 | 26 | 2 | 25003238 | |
| Pubmed | 1.13e-05 | 7 | 26 | 2 | 11860456 | ||
| Pubmed | 1.13e-05 | 7 | 26 | 2 | 20962236 | ||
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 11784029 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.50e-05 | 8 | 26 | 2 | 19033399 | |
| Pubmed | 1.96e-05 | 70 | 26 | 3 | 12036966 | ||
| Pubmed | 2.41e-05 | 10 | 26 | 2 | 17156446 | ||
| Pubmed | 3.53e-05 | 12 | 26 | 2 | 19095005 | ||
| Pubmed | 1.01e-04 | 20 | 26 | 2 | 20716560 | ||
| Pubmed | Circular RNA profile in liver tissue of EpCAM knockout mice. | 1.23e-04 | 22 | 26 | 2 | 31524221 | |
| Pubmed | 2.01e-04 | 28 | 26 | 2 | 23006423 | ||
| Pubmed | 2.45e-04 | 777 | 26 | 5 | 35844135 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 3.72e-04 | 38 | 26 | 2 | 30786075 | |
| Pubmed | 4.35e-04 | 199 | 26 | 3 | 36688959 | ||
| Pubmed | 4.42e-04 | 200 | 26 | 3 | 18240029 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q22 | 5.13e-05 | 127 | 26 | 3 | chr6q22 | |
| Cytoband | 6q22.31 | 1.07e-04 | 27 | 26 | 2 | 6q22.31 | |
| GeneFamily | Glycoprotein hormone receptors | 2.81e-06 | 3 | 18 | 2 | 199 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.81e-06 | 3 | 18 | 2 | 287 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 7.72e-03 | 134 | 18 | 2 | 861 | |
| GeneFamily | EF-hand domain containing | 1.97e-02 | 219 | 18 | 2 | 863 | |
| Coexpression | HOWLIN_PUBERTAL_MAMMARY_GLAND | 3.80e-05 | 66 | 26 | 3 | M1267 | |
| Coexpression | HOWLIN_PUBERTAL_MAMMARY_GLAND | 5.15e-05 | 73 | 26 | 3 | MM533 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-06 | 189 | 26 | 4 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-06 | 189 | 26 | 4 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Ptgfr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.45e-05 | 127 | 26 | 3 | fb58f4b4d3722f4b9a2e4946c0244c5b70dd883b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.53e-05 | 135 | 26 | 3 | 8521107817df49efd9a2e81078c8535ed33e729c | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Prdm8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.10e-05 | 151 | 26 | 3 | 090b067873740c282865e2d02cf47d5cb3dd7607 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.47e-05 | 153 | 26 | 3 | 499670e716fc85ce76630fc813cec86f8419f2a1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 164 | 26 | 3 | 1cb5fbd7050650047ad6f2ca792118e98d58d22b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.51e-04 | 179 | 26 | 3 | 445eeb0356d9fd894aa33dd9f45d893b21424149 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.58e-04 | 182 | 26 | 3 | 35b2a5625323bf0917214d3b82fafc4a8f5e75ff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 184 | 26 | 3 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 184 | 26 | 3 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | CV-Healthy-7|CV / Virus stimulation, Condition and Cluster | 1.63e-04 | 184 | 26 | 3 | 0e5cc77aaa73ceb791f8be7456177577fd2e5586 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 184 | 26 | 3 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.63e-04 | 184 | 26 | 3 | 9a185e6ea86bbfbb48bfe88650a8c05ceba78d7f | |
| ToppCell | facs-Bladder-nan-18m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 185 | 26 | 3 | 3e00879466e626aa8604efecfc4678d64f54dbfc | |
| ToppCell | CV-Healthy-7|Healthy / Virus stimulation, Condition and Cluster | 1.66e-04 | 185 | 26 | 3 | 1979d189c204f4c2893e3170a514ee7d5523406c | |
| ToppCell | facs-Bladder-nan-18m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 185 | 26 | 3 | 3dc5812c961ff209f197ff4cbfb90009c0537550 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 186 | 26 | 3 | 337f768cc43db2db96ba6495b076006b1a5b0331 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 186 | 26 | 3 | e378c82ef6d6cb24751515aa499a01372b3e7ccf | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 188 | 26 | 3 | 4dc89c7843ebd078e3414e835c56f11fa27f0c5f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 188 | 26 | 3 | d577b3c2a844e3062c7ca9e9ebc1722d0ac95caa | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 188 | 26 | 3 | 1e788b60dd643bf220d8dfafa82d85fd083cbc71 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 26 | 3 | e4efbb0733b382f4c855f6653dcddf36e0f8df28 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.79e-04 | 190 | 26 | 3 | 49e09cdb843b3d889a06a811aa5affae68b25a75 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 192 | 26 | 3 | a116db7dec495e5a0ba9c7537057cd1e567d7885 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 192 | 26 | 3 | 9ae05db5bfb8b9d3935c0328e6f2d489d2b1ebfd | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 192 | 26 | 3 | 66defad13bd8e79319741e43ddb056841710b1d7 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.03e-04 | 198 | 26 | 3 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | Neuronal-Excitatory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.09e-04 | 200 | 26 | 3 | 4409065bc7aa995354c71e0f9d6f3726cf393d6b | |
| Drug | myo-inositol | 9.85e-09 | 811 | 26 | 10 | CID000000892 | |
| Drug | 2-hydroxyheptanoic acid | 3.76e-06 | 3 | 26 | 2 | CID002750949 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 3.76e-06 | 3 | 26 | 2 | CID005748312 | |
| Drug | 8N3-cADPR | 3.76e-06 | 3 | 26 | 2 | CID000127713 | |
| Drug | 2-hydroxycarbazole | 3.76e-06 | 3 | 26 | 2 | CID000093551 | |
| Drug | aminodantrolene | 3.76e-06 | 3 | 26 | 2 | CID009570289 | |
| Drug | cis-diammineplatinum(II | 3.76e-06 | 3 | 26 | 2 | CID000159790 | |
| Drug | LOPAC | 5.26e-06 | 30 | 26 | 3 | CID000062696 | |
| Drug | M-HN | 5.82e-06 | 31 | 26 | 3 | CID000015450 | |
| Drug | SC 38249 | 7.51e-06 | 4 | 26 | 2 | CID000134834 | |
| Drug | AC1L1U7A | 7.51e-06 | 4 | 26 | 2 | CID000035682 | |
| Drug | PCB74 | 7.51e-06 | 4 | 26 | 2 | CID000036218 | |
| Drug | 148504-47-6 | 7.51e-06 | 4 | 26 | 2 | CID006444275 | |
| Drug | 1,2-dichlorohexafluorocyclobutane | 1.00e-05 | 37 | 26 | 3 | CID000009643 | |
| Drug | Org 41841 | 1.25e-05 | 5 | 26 | 2 | ctd:C510603 | |
| Drug | Aspartylglutamate | 1.27e-05 | 40 | 26 | 3 | CID000151403 | |
| Drug | AC1O528X | 1.88e-05 | 6 | 26 | 2 | CID006475857 | |
| Drug | NSC114784 | 1.88e-05 | 6 | 26 | 2 | CID000419425 | |
| Drug | MBED | 1.88e-05 | 6 | 26 | 2 | CID000129958 | |
| Drug | thieno[2,3-d]pyrimidine | 1.88e-05 | 6 | 26 | 2 | CID012225304 | |
| Drug | chloro-m-cresol | 1.88e-05 | 6 | 26 | 2 | CID000012008 | |
| Drug | Azumoleno | 2.62e-05 | 7 | 26 | 2 | CID000056259 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 2.62e-05 | 7 | 26 | 2 | CID009547999 | |
| Drug | Br2BAPTA | 2.62e-05 | 7 | 26 | 2 | CID003081001 | |
| Drug | AC1L1KC5 | 2.69e-05 | 541 | 26 | 6 | CID000005428 | |
| Drug | AC1L1KS5 | 3.37e-05 | 334 | 26 | 5 | CID000005631 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | 3.53e-05 | 568 | 26 | 6 | CID000000806 | |
| Drug | fura 2 | 5.51e-05 | 65 | 26 | 3 | CID000057054 | |
| Drug | PCB 95 | 5.61e-05 | 10 | 26 | 2 | CID000038012 | |
| Drug | baclofen | 6.21e-05 | 191 | 26 | 4 | CID000002284 | |
| Drug | NO-cAMP | 6.59e-05 | 69 | 26 | 3 | CID006426615 | |
| Drug | R 478 | 6.85e-05 | 11 | 26 | 2 | CID000084223 | |
| Drug | 8-amino-cADPR | 6.85e-05 | 11 | 26 | 2 | CID003081323 | |
| Drug | PCB 66 | 6.85e-05 | 11 | 26 | 2 | CID000036185 | |
| Drug | Flucloxacillin sodium [1847-24-1]; Down 200; 8.4uM; PC3; HT_HG-U133A | 6.86e-05 | 196 | 26 | 4 | 5102_DN | |
| Drug | (2S,3R)-Sphingosine | 6.94e-05 | 389 | 26 | 5 | CID000001104 | |
| Drug | gadolinium | 7.28e-05 | 199 | 26 | 4 | CID000023982 | |
| Drug | C070379 | 7.28e-05 | 199 | 26 | 4 | CID003034747 | |
| Drug | Ryanodine | 8.22e-05 | 12 | 26 | 2 | ctd:D012433 | |
| Drug | XeC compound | 1.18e-04 | 84 | 26 | 3 | CID000005701 | |
| Drug | FPL 64176 | 1.30e-04 | 15 | 26 | 2 | CID000003423 | |
| Drug | Gvapspat amide | 1.30e-04 | 15 | 26 | 2 | CID000125015 | |
| Drug | 3-(1H-pyrrole-2-carboxylate | 1.34e-04 | 233 | 26 | 4 | CID000005114 | |
| Drug | Picrotoxin | 1.65e-04 | 94 | 26 | 3 | ctd:D010852 | |
| Drug | kazinol B | 1.69e-04 | 17 | 26 | 2 | CID000480869 | |
| Drug | gamma-aminobutyric acid | 1.75e-04 | 474 | 26 | 5 | CID000000119 | |
| Drug | borate | 1.87e-04 | 98 | 26 | 3 | CID000007628 | |
| Drug | methylcoumarin | 1.90e-04 | 18 | 26 | 2 | CID000007092 | |
| Drug | indo-1 | 1.93e-04 | 99 | 26 | 3 | CID000105060 | |
| Drug | AC1L380G | 2.12e-04 | 19 | 26 | 2 | CID000084698 | |
| Drug | AC1MW7VF | 2.12e-04 | 19 | 26 | 2 | CID000414699 | |
| Drug | indo-1/AM | 2.60e-04 | 21 | 26 | 2 | CID000123918 | |
| Drug | fluo-3 | 3.57e-04 | 122 | 26 | 3 | CID000104978 | |
| Drug | A-26 | 3.70e-04 | 25 | 26 | 2 | CID000037120 | |
| Drug | T0702 | 3.70e-04 | 25 | 26 | 2 | CID000005908 | |
| Drug | Kn 04 | 4.01e-04 | 26 | 26 | 2 | CID000131117 | |
| Drug | AC1L1IZE | 4.39e-04 | 131 | 26 | 3 | CID000004799 | |
| Drug | BAPTA | 4.70e-04 | 324 | 26 | 4 | CID000104751 | |
| Drug | GTP[S] | 4.85e-04 | 591 | 26 | 5 | CID000001764 | |
| Drug | 2,4-xylidinothiazoline | 5.35e-04 | 30 | 26 | 2 | CID000099296 | |
| Drug | SBFI | 5.35e-04 | 30 | 26 | 2 | CID000123881 | |
| Drug | carboxyamidotriazole | 5.71e-04 | 31 | 26 | 2 | CID000108144 | |
| Drug | Dantrolene-13C3 | 5.91e-04 | 145 | 26 | 3 | CID000002951 | |
| Drug | nimodipine | 5.91e-04 | 145 | 26 | 3 | CID000004497 | |
| Drug | salicylhydroxamic acid | 6.03e-04 | 146 | 26 | 3 | CID000066644 | |
| Drug | M3/M4 | 6.09e-04 | 32 | 26 | 2 | CID000486507 | |
| Drug | CNS 1145 | 6.48e-04 | 33 | 26 | 2 | CID000190902 | |
| Drug | IHC-64 | 6.48e-04 | 33 | 26 | 2 | CID000162753 | |
| Drug | CHAPS detergent | 7.58e-04 | 158 | 26 | 3 | CID000107670 | |
| Drug | phorbol acetate myristate | 7.61e-04 | 1399 | 26 | 7 | CID000004792 | |
| Drug | lidocaine | 7.86e-04 | 160 | 26 | 3 | CID000003676 | |
| Drug | 4-chloro-m-cresol | 8.15e-04 | 37 | 26 | 2 | CID000001732 | |
| Drug | mag-fura-2 | 8.15e-04 | 37 | 26 | 2 | CID000123839 | |
| Drug | forskolin from Coleus forskohlii | 8.18e-04 | 1013 | 26 | 6 | CID000003413 | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 2.24e-06 | 3 | 26 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 2.24e-06 | 3 | 26 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | Tourette syndrome | 8.91e-04 | 50 | 26 | 2 | EFO_0004895 | |
| Disease | platelet crit | 1.29e-03 | 952 | 26 | 5 | EFO_0007985 | |
| Disease | smooth surface dental caries | 1.37e-03 | 62 | 26 | 2 | EFO_0006339 | |
| Disease | acute lymphoblastic leukemia | 1.55e-03 | 66 | 26 | 2 | EFO_0000220 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CVFLGPDYQVYICIA | 1181 | Q96NH3 | |
| VVAFFIICACYIKIY | 536 | P22888 | |
| LIVDGRVYYICIVCK | 486 | Q86T24 | |
| VTLYCFVYGKCPFID | 341 | Q8N5S9 | |
| TLPVLYLCEFCLKYG | 256 | Q92993 | |
| IKPSLVCCEGYIYAI | 371 | Q8IY47 | |
| KEYLCKYAIPCLIGI | 176 | P42356 | |
| IICVCYYVAVFPFIG | 271 | Q9H3U5 | |
| YCIAAAVVVVTYPVC | 231 | A6NFX1 | |
| FKYVLLPVSYGVVCV | 31 | P41231 | |
| LYCTFIPKCYVIICK | 826 | Q5T6X5 | |
| DCSIYKKYPVVAIPC | 31 | P58062 | |
| CYIILAGIFLGYVCP | 631 | Q13255 | |
| VISFFCIIGYYCLKV | 4581 | Q92736 | |
| CIIGYYCLKVPLVIF | 4586 | Q92736 | |
| VFCGKELYGYLCVIK | 301 | Q68D06 | |
| YRILGKTVVCYPIIF | 566 | Q93100 | |
| CVGCFIFSLVKYVPL | 516 | P31641 | |
| YICCNFLYISPEKGI | 501 | Q8NEA9 | |
| KIVYYEAGIILCCVL | 101 | O43490 | |
| VVIGLFVFPIYCLCK | 516 | Q8TC41 | |
| CQVLVAIPYLYCTFI | 141 | Q8NH51 | |
| VCVIVVPFFLCYNYP | 251 | Q8IWX5 | |
| IISLVCVVGYYCLKV | 4486 | Q15413 | |
| CVVGYYCLKVPLVVF | 4491 | Q15413 | |
| LTLEKYICIVYPFRC | 506 | Q9HBX9 | |
| PFVVYCQYKEPLLEC | 396 | Q9UJA5 | |
| IVAFVIVCCCYVKIY | 591 | P16473 |